Clinical Trial Update: TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Hyalgan three-injection regimen for knee pain due to osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Hyalgan (sodium hyaluronate)

Snippet

Sponsor: Sanofi | Conditions: Osteoarthritis | Phase 4 | Status: COMPLETED